Status:

COMPLETED

Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT

Lead Sponsor:

University of Kansas Medical Center

Collaborating Sponsors:

Penumbra Inc.

Conditions:

Acute Deep Vein Thrombosis

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

The purpose of this study is to demonstrate the safety and efficacy of thrombolysis in combination with endhole aspiration in the treatment of acute deep vein thrombosis (DVT). Secondarily, the study ...

Eligibility Criteria

Inclusion

  • Over 18 years of age
  • Onset of acute DVT occurred \<14 days
  • Ability to undergo thrombolysis in combination with Indigo endhole aspiration device

Exclusion

  • Under 18 years of age
  • Presence of subacute (14-28 days) or chronic DVT (\>28 days)
  • Contraindication to mechanical thrombectomy

Key Trial Info

Start Date :

September 23 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 16 2023

Estimated Enrollment :

3 Patients enrolled

Trial Details

Trial ID

NCT04297787

Start Date

September 23 2020

End Date

June 16 2023

Last Update

June 22 2023

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

University of Kansas Medical Center

Kansas City, Kansas, United States, 66160

Safety and Efficacy of Thrombolysis in Combination With Endhole Aspiration in the Treatment of Acute DVT | DecenTrialz